{"organizations": [], "uuid": "f92cfe26bbdaa5c398c1e3b124972aed215c0a6a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180119.html", "section_title": "Archive News &amp; Video for Friday, 19 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/products-testosterone/7th-circuit-upholds-dismissal-of-testosterone-replacement-mdl-cases-idUSL1N1PF00V", "country": "US", "domain_rank": 408, "title": "7th Circuit upholds dismissal of testosterone replacement MDL cases", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-01-20T08:22:00.000+02:00", "replies_count": 0, "uuid": "f92cfe26bbdaa5c398c1e3b124972aed215c0a6a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/products-testosterone/7th-circuit-upholds-dismissal-of-testosterone-replacement-mdl-cases-idUSL1N1PF00V", "ord_in_thread": 0, "title": "7th Circuit upholds dismissal of testosterone replacement MDL cases", "locations": [], "entities": {"persons": [{"name": "matthew kennelly", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "7th circuit", "sentiment": "negative"}, {"name": "westlaw", "sentiment": "none"}, {"name": "7th circuit u.s. court of appeals", "sentiment": "none"}, {"name": "pfizer inc", "sentiment": "none"}, {"name": "u.s. food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "A federal appeals court on Friday affirmed the dismissal of more than a thousand lawsuits by men who used Pfizer Inc testosterone replacement drug Depo-T, finding the claims were preempted by U.S. Food and Drug Administration approval of the medicationâ€™s label.\nIn a unanimous decision, a three-judge panel of the 7th Circuit U.S. Court of Appeals ruled that U.S. District Judge Matthew Kennelly, who oversees the multidistrict litigation over Depo-T and similar drugs, correctly dismissed the lawsuits in 2015.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2DqBVz1\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2DqBVz1"], "published": "2018-01-20T08:22:00.000+02:00", "crawled": "2018-01-20T17:31:16.000+02:00", "highlightTitle": ""}